Complementary and alternative medicines (CAM) are frequently given to children and adolescents for reputed benefits for hyperkinetic and concentration disorders such as attention deficit hyperactivity disorder (ADHD).
Archive for the 'Pine Bark Extract' Category
Ms. Meenakshi Khatta is a nurse practitioner and associate professor at the University of Maryland in Baltimore. Nurse Khatta has reviewed the use of CAM to treat pain due to musculoskeletal conditions.
The World Health Organization has predicted a 39% rise in the worldwide prevalence of diabetes by 2030. And an article in The Lancet indicates this might be an underestimation.
Since November is Diabetes Month, here’s a round-up of CAM options for people with diabetes from 2006 through March 2007.
This is apparently the first study of pycnogenol (French maritime pine bark extract) to treat peri-menopausal symptoms. (more…)
In the past year, several studies on this topic have appeared. The results are positive.
So, let’s review.
The Centers for Disease Control has just published the latest data on the prevalence of diabetes in the US.
- 11% of adults aged 40 to 59 years
- 23% of those 60 and older have diabetes
Is it any wonder that so many CAM therapies are studied in people with diabetes?
A quick listing of CAM entries for diabetes on this blog is provided below. Or, click the button on the right sidebar to see all of the diabetes entries.
One of the major complications of diabetes mellitus is the change in small blood vessels called microangiopathy. It’s associated with kidney failure and blindness, as well as other conditions such as diabetic ulcers.
Here are the results of a study of pycnogenol in people with diabetic ulcers.
Here are the results from two studies that support the role of pycnogenol (pronounced pick-nah-geh-nol) to treat ADHD (attention deficit/hyperactivity disorder).
Six years ago I wrote an article about pycnogenol. It was a story about a man (Dr. Jacques Masquelier), his invention (the extraction process), and alleged trademark infringement, which prevents him from selling his product in the United States.
Pycnogenol is a scavenger of oxygen free radicals, and Dr. Masquelier’s website presents a long list of benefits attributed to pycnogenol. We await the supporting clinical trial results, however.
The point of this post is to update that original article. Dr. Masquelier (in his late 80s) is retired. His successors continue to defend the extraction process and their product.
7/1/06 9:33 JR